Gilteritinib Impurities refer to the unwanted substances or by-products that may be present in Gilteritinib drug substance or drug product during its synthesis, manufacturing, or storage. These impurities can affect the quality, safety, and efficacy of the drug and need to be identified, characterized, and controlled within acceptable limits. Gilteritinib Impurities can be organic or inorganic in nature and may include starting materials, intermediates, degradation products, and other related compounds. Effective impurity
